03.24.14
Bioactives American Corporation, a specialty ingredient company that develops and sells science-based formulations for health and wellness, has developed a branded proprietary Salacia oblonga extract, Salsulin, to help manage insulin and blood sugar levels. S. oblanga is a safe, non-toxic herbal extract that has been used for thousands of years in Ayurvedic medicine for the oral treatment of diabetes, by helping naturally regulate blood sugar and insulin.
Salsulin is a self-affirmed GRAS ingredient manufactured using cGMP standards. Bioactives American’s Salsulin can be used as a Medical Foods at a dose of 480 mg/60 kg body weight/day. In addition, due to the GRAS status, it can be used as a food additive in conventional foods such as teas and soups.
A randomized, double-blinded crossover study with S.oblonga (Williams et al. 2007) evaluated the effect of a S. oblonga extract on postprandial glycemia and insulinemia in 61 patients with type 2 diabetes after ingestion of a high carbohydrate meal. In a fasted state, subjects consumed one of 3 meals: a standard liquid control meal, a control meal + 240 mg S. oblonga extract, and a control meal + 480 mg S. oblonga extract. Serum glucose and insulin samples were measured at baseline and at postprandial intervals up to 180 minutes. The results from the study showed that both doses of theS. oblonga extract significantly lowered the postprandial positive area under the glucose curve and the adjusted peak glucose response compared to the control meal with the higher dose performing better.
For more information: www.bioactivesamerica.com
Salsulin is a self-affirmed GRAS ingredient manufactured using cGMP standards. Bioactives American’s Salsulin can be used as a Medical Foods at a dose of 480 mg/60 kg body weight/day. In addition, due to the GRAS status, it can be used as a food additive in conventional foods such as teas and soups.
A randomized, double-blinded crossover study with S.oblonga (Williams et al. 2007) evaluated the effect of a S. oblonga extract on postprandial glycemia and insulinemia in 61 patients with type 2 diabetes after ingestion of a high carbohydrate meal. In a fasted state, subjects consumed one of 3 meals: a standard liquid control meal, a control meal + 240 mg S. oblonga extract, and a control meal + 480 mg S. oblonga extract. Serum glucose and insulin samples were measured at baseline and at postprandial intervals up to 180 minutes. The results from the study showed that both doses of theS. oblonga extract significantly lowered the postprandial positive area under the glucose curve and the adjusted peak glucose response compared to the control meal with the higher dose performing better.
For more information: www.bioactivesamerica.com